Japan's Panasonic Corp has appointed its head of automotive business Yuki Kusumi as the company's next chief executive officer, replacing Kazuhiro Tsuga, who was the architect of a partnership with Tesla Inc.
The international market for higher education is worth billions of dollars. But with borders closed because of COVID-19 and lessons moved online, some are asking whether going abroad to study still makes sense. Money Mind reports.
Swedish telecoms regulator PTS will pause the upcoming 5G auction and appeal a court ruling against its decision to exclude Chinese telecom equipment maker Huawei from its 5G networks.
Tesla CEO Elon Musk questioned the accuracy of COVID-19 tests on Thursday (Nov 12) after claiming that results showed he tested positive twice and then negative twice all on the same day.
Russian online retailer Ozon plans to raise about US$750 million in an initial public offering (IPO) in the United States, three financial market sources told Reuters.
BANGKOK: Travel website Tripadvisor has slapped a warning on a Thai resort's listing, after it launched legal action against an American expat over a negative review, which briefly landed him in prison. In July, Wesley Barnes wrote of encountering "unfriendly staff" and accused the Sea View hotel ...
Tesla Inc Chief Executive Elon Musk said on Thursday that he took four coronavirus tests on the same day with two returning negative and two producing positive results.
WASHINGTON: Only a few of America's CEOs have made public statements about President Donald Trump's refusal to accept his election loss, but in private, many are alarmed and talking about what collective action would be necessary if they see an imminent threat to democracy. On Nov 6, more than two ......
IN a move to boost mental well-being, the majority of UOB's 26,000-strong workforce will have the option to work remotely two days a week once Covid-19 restrictions are lifted, announced the bank on Friday.
French healthcare giant Sanofi has invested 50 million euros (US$59 million) into Jeito Capital, an investment firm dedicated to biotech and biopharma, in a deal which Sanofi said would support French and European healthcare innovation.
